%0 Journal Article %1 citeulike:14420674 %A Ridker, Paul M. %A Everett, Brendan M. %A Thuren, Tom %A MacFadyen, Jean G. %A Chang, William H. %A Ballantyne, Christie %A Fonseca, Francisco %A Nicolau, Jose %A Koenig, Wolfgang %A Anker, Stefan D. %A Kastelein, John J. P. %A Cornel, Jan H. %A Pais, Prem %A Pella, Daniel %A Genest, Jacques %A Cifkova, Renata %A Lorenzatti, Alberto %A Forster, Tamas %A Kobalava, Zhanna %A Vida-Simiti, Luminita %A Flather, Marcus %A Shimokawa, Hiroaki %A Ogawa, Hisao %A Dellborg, Mikael %A Rossi, Paulo R. F. %A Troquay, Roland P. T. %A Libby, Peter %A Glynn, Robert J. %D 2017 %I Massachusetts Medical Society %J N Engl J Med %K cardiovascular, citeulikeExport examfodder, exampearl, immunology %N 12 %P 1119--1131 %R 10.1056/nejmoa1707914 %T Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease %U http://dx.doi.org/10.1056/nejmoa1707914 %V 377 %X Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The 150-mg dose, but not the 50-mg or 300-mg dose, led to a lower incidence of recurrent cardiovascular events.

@article{citeulike:14420674, abstract = {{Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The 150-mg dose, but not the 50-mg or 300-mg dose, led to a lower incidence of recurrent cardiovascular events.}}, added-at = {2019-03-31T01:14:40.000+0100}, author = {Ridker, Paul M. and Everett, Brendan M. and Thuren, Tom and MacFadyen, Jean G. and Chang, William H. and Ballantyne, Christie and Fonseca, Francisco and Nicolau, Jose and Koenig, Wolfgang and Anker, Stefan D. and Kastelein, John J. P. and Cornel, Jan H. and Pais, Prem and Pella, Daniel and Genest, Jacques and Cifkova, Renata and Lorenzatti, Alberto and Forster, Tamas and Kobalava, Zhanna and Vida-Simiti, Luminita and Flather, Marcus and Shimokawa, Hiroaki and Ogawa, Hisao and Dellborg, Mikael and Rossi, Paulo R. F. and Troquay, Roland P. T. and Libby, Peter and Glynn, Robert J.}, biburl = {https://www.bibsonomy.org/bibtex/2861fb0dab3632e4fae0555f6c1df2745/dianella}, citeulike-article-id = {14420674}, citeulike-linkout-0 = {http://dx.doi.org/10.1056/nejmoa1707914}, citeulike-linkout-1 = {http://www.nejm.org/doi/abs/10.1056/NEJMoa1707914}, day = 27, doi = {10.1056/nejmoa1707914}, interhash = {f87f016236f8fd73204fc6b0bffb20aa}, intrahash = {861fb0dab3632e4fae0555f6c1df2745}, journal = {N Engl J Med}, keywords = {cardiovascular, citeulikeExport examfodder, exampearl, immunology}, month = aug, number = 12, pages = {1119--1131}, posted-at = {2018-04-25 08:42:06}, priority = {2}, publisher = {Massachusetts Medical Society}, timestamp = {2019-03-31T01:16:26.000+0100}, title = {{Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease}}, url = {http://dx.doi.org/10.1056/nejmoa1707914}, volume = 377, year = 2017 }